Introduction It has been almost a year since the last time I covered Honeywell International (NASDAQ:HON), and with the recent announcement of an acquisition,...
Here’s a look at the next iteration of Pfizer’s (NYSE:PFE, NEOE:PFE:CA) now-well-known antiviral, Paxlovid. As those who have taken it know, the treatment consists,...
More investors are asking the question lately, in part because markets are seemingly defying gravity and ignoring various macro and geopolitical risks. Yet, a...
Investment Thesis I last reviewed the Federated Hermes U.S. Strategic Dividend ETF (NYSEARCA:FDV) on December 9, 2022, when I questioned whether this new, actively...